Two novel ATP8B1 mutations involved in progressive familial intrahepatic cholestasis type 1 that is ameliorated by rifampicin: A case report
Authors:
Open Access
- 22 February 2022
- journal article
- letter
- Published by Wiley in Journal of Digestive Diseases
- Vol. 23 (2) , 124-129
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Sequencing of FIC1, BSEP and MDR3 in a large cohort of patients with cholestasis revealed a high number of different genetic variantsJournal of Hepatology, 2017
- P4-ATPases as Phospholipid Flippases—Structure, Function, and EnigmasFrontiers in Physiology, 2016
- Rifampicin in the treatment of severe intrahepatic cholestasis of pregnancyEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 2015
- Novel splice‐site mutation in ATP8B1 results in atypical Progressive Familial Intrahepatic Cholestasis Type 1Journal of Gastroenterology and Hepatology, 2013
- Phospholipase D2 mediates signaling by ATPase class I type 8B membrane 1Journal of Lipid Research, 2013
- Activity of the Bile Salt Export Pump (ABCB11) Is Critically Dependent on Canalicular Membrane Cholesterol ContentJournal of Biological Chemistry, 2009
- Atp8b1 deficiency in mice reduces resistance of the canalicular membrane to hydrophobic bile salts and impairs bile salt transportHepatology, 2006
- Complementary Stimulation of Hepatobiliary Transport and Detoxification Systems by Rifampicin and Ursodeoxycholic Acid in HumansGastroenterology, 2005
- Familial intrahepatic cholestasis 1: Studies of localization and functionHepatology, 2001
- A gene encoding a P-type ATPase mutated in two forms of hereditary cholestasisNature Genetics, 1998